Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Astrocyte Pharmaceuticals

    Client Virtual Booth

    ASTROCYTE PHARMACEUTICALS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Astrocyte Pharmaceuticals
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    93 Shennecossett Road, Groton, CT 06340
    Telephone
    Telephone
    +1 617-444-8765
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.astrocytepharma.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Astrocyte Announces FDA Clearance of its Investigational NDA for AST-004
    Astrocyte Announces FDA Clearance of its Investigational NDA for AST-004

    https://www.globenewswire.com//news-release/2024/03/12/2844784/0/en/Astrocyte-Pharmaceuticals-Announces-FDA-Clearance-of-its-Investigational-New-Drug-Application-for-AST-004.html

    GLOBENEWSWIRE
    12 Mar 2024
    Share Share
    Alzheimer's Drug Discovery Foundation Joins Astrocyte’s $6M Financing Round
    Alzheimer's Drug Discovery Foundation Joins Astrocyte’s $6M Financing Round

    https://www.businesswire.com/news/home/20230818032516/en

    BUSINESSWIRE
    18 Aug 2023
    Share Share
    Astrocyte Announces Theodore Liston, Ph.D., Vice President of Research
    Astrocyte Announces Theodore Liston, Ph.D., Vice President of Research

    https://www.businesswire.com/news/home/20230410005135/en

    BUSINESSWIRE
    10 Apr 2023
    Share Share
    Astrocyte Announces Initiation of an Extended Infusion Phase 1B Study of AST-004
    Astrocyte Announces Initiation of an Extended Infusion Phase 1B Study of AST-004

    https://www.businesswire.com/news/home/20230405005629/en

    BUSINESSWIRE
    05 Apr 2023
    Share Share
    Astrocyte Pharma Presents Update on AST-004 Clinical Program at 2022 Symposium
    Astrocyte Pharma Presents Update on AST-004 Clinical Program at 2022 Symposium

    https://www.businesswire.com/news/home/20220914005969/en

    BUSINESSWIRE
    14 Sep 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search